Clinical studies have confirmed significant imbalances in Trp metabolism in the peripheral blood and skin lesion tissues of psoriasis patients: On one hand, levels of protective indole metabolites with AhR-activating activity (e.g., IPA, IAld) are markedly reduced. The gene discussed is AHR; the disease is psoriasis.